Legis Daily

FAUCI Act

USA117th CongressS-3159| Senate 
| Updated: 11/3/2021
Joni Ernst

Joni Ernst

Republican Senator

Iowa

Cosponsors (4)
Mike Braun (Republican)Roger F. Wicker (Republican)John Thune (Republican)Marco Rubio (Republican)

Foreign Relations Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Fairness and Accountability in Underwriting Chinese Institutions Act or the FAUCI Act This bill prohibits making any federal funding available to laboratories or research institutions in China for gain-of-function research. The President may waive this prohibition for national security interests. (Under the bill, gain-of-function research generally involves the enhancement of potential pandemic pathogens or related risky research with potentially dangerous pathogens.) Furthermore, if the Office of the Inspector General of the Department of Health and Human Services determines that a National Institutes of Health official, employee, or grantee has intentionally misled or omitted information in a relevant disclosure (e.g., to Congress) about federal funding for international gain-of-function research, such a person shall be ineligible for any federal funding or federal employment.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Nov 3, 2021
Introduced in Senate
Nov 3, 2021
Read twice and referred to the Committee on Foreign Relations.
Jan 20, 2022

Latest Companion Bill Action

HR 117-6447
Introduced in House
  • November 3, 2021
    Introduced in Senate


  • November 3, 2021
    Read twice and referred to the Committee on Foreign Relations.


  • January 20, 2022

    Latest Companion Bill Action

    HR 117-6447
    Introduced in House

International Affairs

Related Bills

  • HR 117-5988: FAUCI Act
AsiaCardiovascular and respiratory healthChinaCongressional oversightDepartment of Health and Human ServicesDrug trafficking and controlled substancesGovernment employee pay, benefits, personnel managementGovernment ethics and transparency, public corruptionGovernment studies and investigationsHealth programs administration and fundingInfectious and parasitic diseasesMedical researchNational Institutes of Health (NIH)Public contracts and procurementResearch administration and fundingWorld health

FAUCI Act

USA117th CongressS-3159| Senate 
| Updated: 11/3/2021
Fairness and Accountability in Underwriting Chinese Institutions Act or the FAUCI Act This bill prohibits making any federal funding available to laboratories or research institutions in China for gain-of-function research. The President may waive this prohibition for national security interests. (Under the bill, gain-of-function research generally involves the enhancement of potential pandemic pathogens or related risky research with potentially dangerous pathogens.) Furthermore, if the Office of the Inspector General of the Department of Health and Human Services determines that a National Institutes of Health official, employee, or grantee has intentionally misled or omitted information in a relevant disclosure (e.g., to Congress) about federal funding for international gain-of-function research, such a person shall be ineligible for any federal funding or federal employment.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Nov 3, 2021
Introduced in Senate
Nov 3, 2021
Read twice and referred to the Committee on Foreign Relations.
Jan 20, 2022

Latest Companion Bill Action

HR 117-6447
Introduced in House
  • November 3, 2021
    Introduced in Senate


  • November 3, 2021
    Read twice and referred to the Committee on Foreign Relations.


  • January 20, 2022

    Latest Companion Bill Action

    HR 117-6447
    Introduced in House
Joni Ernst

Joni Ernst

Republican Senator

Iowa

Cosponsors (4)
Mike Braun (Republican)Roger F. Wicker (Republican)John Thune (Republican)Marco Rubio (Republican)

Foreign Relations Committee

International Affairs

Related Bills

  • HR 117-5988: FAUCI Act
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
AsiaCardiovascular and respiratory healthChinaCongressional oversightDepartment of Health and Human ServicesDrug trafficking and controlled substancesGovernment employee pay, benefits, personnel managementGovernment ethics and transparency, public corruptionGovernment studies and investigationsHealth programs administration and fundingInfectious and parasitic diseasesMedical researchNational Institutes of Health (NIH)Public contracts and procurementResearch administration and fundingWorld health